Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9555706 | 0.93 | CA1 (0.46) | TSHRESR1ESR2CA1CA2 | |
| SCHEMBL85540 | 0.89 | TSHR (0.63) | TSHRCETPCA1CA2CA9 | |
| SCHEMBL7431191 | 0.88 | L3MBTL1 (0.51) | TSHRCETPL3MBTL1PKMTDP1 | |
| SCHEMBL9555697 | 0.84 | TDP1 (0.45) | TSHRESR1ESR2CA1CA2 | |
| SCHEMBL7265454 | 0.84 | NPSR1 (0.43) | TSHRCA1CA2CA9L3MBTL1 | |
| SCHEMBL7377074 | 0.81 | L3MBTL1 (0.56) | TSHRL3MBTL1PKMNPC1RAB9A | |
| SCHEMBL11120021 | 0.81 | TSHR (0.55) | TSHRESR1ESR2CETPCA1 | |
| SCHEMBL9555702 | 0.81 | L3MBTL1 (0.43) | TSHRCA1CA2CA9L3MBTL1 | |
| SCHEMBL28209116 | 0.81 | CA1 (0.46) | TSHRESR1ESR2CA1CA2 | |
| SCHEMBL11288205 | 0.80 | TSHR (0.53) | TSHRCETPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5389612-A | Treating infections caused by clostridium histolyticum and pseudomonas aeruginosa; enzyme inhibitors | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1995-02-14 | — | — | US | disclosed |